Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04515602 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study title expanded, about 1 wordv3
  2. Interventions: Neoadjuvant chemotherapy (Procedure), Primary debulking surgery (Procedure) to Neoadjuvant chemotherapy (Procedure), PARPi (Drug), Primary debulking surgery (Procedure)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to answer the fundamental question 'The Optimal Timing of Surgery' in advanced ovarian cancer patients with different tumor burden, and to perform translational study.
Trial Details
NCT Number NCT04515602
Lead Sponsor Shanghai Gynecologic Oncology Group
Collaborators: Obstetrics & Gynecology Hospital of Fudan University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai First Maternity and Infant Hospital
Conditions
(from sponsor)		 Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Related terms Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms
Enrollment 410 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov